Roche strikes an €87.5M dis­cov­ery deal with Con­fo; On­cono­va out-li­cens­es pre­clin­i­cal drug to Chi­na's HanX

→ Bel­gian biotech Con­fo Ther­a­peu­tics is get­ting some sig­nif­i­cant sup­port from Roche. The phar­ma gi­ant is sup­ply­ing €6 mil­lion over the next 30 months …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.